• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic factors for multiple myeloma in the era of novel agents.

作者信息

Bladé J, Rosiñol L, Cibeira M T

机构信息

Institut of Hematology and Oncology, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.

出版信息

Ann Oncol. 2008 Sep;19 Suppl 7:vii117-20. doi: 10.1093/annonc/mdn437.

DOI:10.1093/annonc/mdn437
PMID:18790932
Abstract
摘要

相似文献

1
Prognostic factors for multiple myeloma in the era of novel agents.新型药物时代多发性骨髓瘤的预后因素
Ann Oncol. 2008 Sep;19 Suppl 7:vii117-20. doi: 10.1093/annonc/mdn437.
2
Multiple myeloma.多发性骨髓瘤
Clin Obstet Gynecol. 2002 Sep;45(3):928-38. doi: 10.1097/00003081-200209000-00038.
3
A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents.一种用于预测新型治疗药物时代多发性骨髓瘤患者预后的新分期系统。
Eur J Haematol. 2015 Feb;94(2):145-51. doi: 10.1111/ejh.12407. Epub 2014 Jul 24.
4
[Multiple myeloma].[多发性骨髓瘤]
Ther Umsch. 1996 Feb;53(2):147-51.
5
Advances in the management of myeloma.
Scott Med J. 2005 May;50(2):47-50. doi: 10.1177/003693300505000201.
6
[Multiple myeloma].[多发性骨髓瘤]
Dtsch Med Wochenschr. 2012 Mar;137 Suppl 1:S14-7. doi: 10.1055/s-0032-1301853. Epub 2012 Mar 21.
7
Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.1q21获得与MYC易位并存定义了超二倍体多发性骨髓瘤的一个预后不良亚组。
Haematologica. 2016 Mar;101(3):e116-9. doi: 10.3324/haematol.2015.136929. Epub 2015 Nov 26.
8
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma.骨髓瘤遗传学进展及多发性骨髓瘤的药物基因组学检测前景
Am J Pharmacogenomics. 2005;5(1):35-43. doi: 10.2165/00129785-200505010-00003.
9
The treatment of myeloma.
S Afr Med J. 1979 Nov 17;56(21):821-3.
10
Recurrent Cytogenetic Abnormalities in Multiple Myeloma.多发性骨髓瘤中的复发性细胞遗传学异常
Methods Mol Biol. 2017;1541:295-302. doi: 10.1007/978-1-4939-6703-2_23.

引用本文的文献

1
An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients.基于临床和分子特征的交互式列线图预测多发性骨髓瘤患者的预后。
Aging (Albany NY). 2021 Jul 14;13(14):18442-18463. doi: 10.18632/aging.203294.
2
Distinct Clinical Features of Plasma Cell Myeloma Patients Exhibiting Dysmorphic Plasma Cells: Association with More Plasma Cells at Diagnosis.表现为异形浆细胞的浆细胞骨髓瘤患者的独特临床特征：与诊断时更多的浆细胞相关。
Indian J Hematol Blood Transfus. 2019 Oct;35(4):662-672. doi: 10.1007/s12288-019-01112-x. Epub 2019 Mar 15.
3
Clinicopathological significance of the hypermethylation in multiple myeloma, a systematic review and meta-analysis.
多发性骨髓瘤中高甲基化的临床病理意义：一项系统评价和荟萃分析
Oncotarget. 2017 Jun 27;8(47):83270-83279. doi: 10.18632/oncotarget.18742. eCollection 2017 Oct 10.
4
Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.硼替佐米为主的不同治疗方案对中国骨髓瘤患者的长期疗效
Onco Targets Ther. 2016 Jan 28;9:587-95. doi: 10.2147/OTT.S97457. eCollection 2016.
5
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.全基因组关联研究确定6q25.1处的变异与多发性骨髓瘤的生存率相关。
Nat Commun. 2016 Jan 8;7:10290. doi: 10.1038/ncomms10290.
6
The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.基于硼替佐米的新诊断多发性骨髓瘤患者治疗方案的选择。
PLoS One. 2014 Jun 11;9(6):e99174. doi: 10.1371/journal.pone.0099174. eCollection 2014.
7
Pomalidomide: a review of its use in patients with recurrent multiple myeloma.泊马度胺：一项用于复发性多发性骨髓瘤患者的综述。
Drugs. 2014 Apr;74(5):549-62. doi: 10.1007/s40265-014-0196-6.
8
Prevalence of p16 methylation and prognostic factors in plasma cell myeloma at a single institution in Korea.韩国某单一机构浆细胞骨髓瘤中 p16 甲基化的流行情况及预后因素。
Ann Lab Med. 2013 Jan;33(1):28-33. doi: 10.3343/alm.2013.33.1.28. Epub 2012 Dec 17.
9
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.聚乙二醇脂质体阿霉素：在转移性乳腺癌、卵巢癌、多发性骨髓瘤和艾滋病相关卡波济肉瘤中的应用综述。
Drugs. 2011 Dec 24;71(18):2531-58. doi: 10.2165/11207510-000000000-00000.
10
Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.来那度胺：治疗复发性或难治性多发性骨髓瘤的研究进展。
Drugs. 2011 Mar 26;71(5):625-49. doi: 10.2165/11206420-000000000-00000.